These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 12182110)

  • 41. Acute toxicity and cancer risk assessment values for tert-butyl acetate.
    Budroe JD; Brown JP; Salmon AG; Marty MA
    Regul Toxicol Pharmacol; 2004 Oct; 40(2):168-76. PubMed ID: 15450719
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An evaluation of the mode of action framework for mutagenic carcinogens case study: Cyclophosphamide.
    McCarroll N; Keshava N; Cimino M; Chu M; Dearfield K; Keshava C; Kligerman A; Owen R; Protzel A; Putzrath R; Schoeny R
    Environ Mol Mutagen; 2008 Mar; 49(2):117-31. PubMed ID: 18240158
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Statistics for risk assessment of chemical carcinogens.
    Chen JJ; Chen YJ; Cheng KF
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2007; 25(4):281-312. PubMed ID: 18000784
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Addressing nonlinearity in the exposure-response relationship for a genotoxic carcinogen: cancer potency estimates for ethylene oxide.
    Kirman CR; Sweeney LM; Teta MJ; Sielken RL; Valdez-Flores C; Albertini RJ; Gargas ML
    Risk Anal; 2004 Oct; 24(5):1165-83. PubMed ID: 15563286
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Can systems toxicology identify common biomarkers of non-genotoxic carcinogenesis?
    Plant N
    Toxicology; 2008 Dec; 254(3):164-9. PubMed ID: 18674585
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Carcinogenicity categorization of chemicals-new aspects to be considered in a European perspective.
    Bolt HM; Foth H; Hengstler JG; Degen GH
    Toxicol Lett; 2004 Jun; 151(1):29-41. PubMed ID: 15177638
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Exposure to heterocyclic aromatic amines from the consumption of cooked red meat and its effect on human cancer risk: a review.
    Alaejos MS; González V; Afonso AM
    Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2008 Jan; 25(1):2-24. PubMed ID: 17952757
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 4-nitroquinoline-1-oxide induced experimental oral carcinogenesis.
    Kanojia D; Vaidya MM
    Oral Oncol; 2006 Aug; 42(7):655-67. PubMed ID: 16448841
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Methyl tertiary-butyl ether mode of action for cancer endpoints in rodents.
    Cruzan G; Borghoff SJ; de Peyster A; Hard GC; McClain M; McGregor DB; Thomas MG
    Regul Toxicol Pharmacol; 2007 Mar; 47(2):156-65. PubMed ID: 17084497
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The stability of historical control data for common neoplasms in laboratory rats and the implications for carcinogenic risk assessment.
    Tennekes H; Kaufmann W; Dammann M; van Ravenzwaay B
    Regul Toxicol Pharmacol; 2004 Dec; 40(3):293-304. PubMed ID: 15546683
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Arsenic cancer risk posed to human health from tilapia consumption in Taiwan.
    Liao CM; Shen HH; Lin TL; Chen SC; Chen CL; Hsu LI; Chen CJ
    Ecotoxicol Environ Saf; 2008 May; 70(1):27-37. PubMed ID: 18068227
    [TBL] [Abstract][Full Text] [Related]  

  • 52. How to address human interindividual variation in the process of animal extrapolation.
    Calabrese EJ
    Prog Clin Biol Res; 1990; 340D():315-22. PubMed ID: 2371303
    [No Abstract]   [Full Text] [Related]  

  • 53. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analysis of in vivo mutation data can inform cancer risk assessment.
    Moore MM; Heflich RH; Haber LT; Allen BC; Shipp AM; Kodell RL
    Regul Toxicol Pharmacol; 2008 Jul; 51(2):151-61. PubMed ID: 18321622
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Do extremely low frequency magnetic fields enhance the effects of environmental carcinogens? A meta-analysis of experimental studies.
    Juutilainen J; Kumlin T; Naarala J
    Int J Radiat Biol; 2006 Jan; 82(1):1-12. PubMed ID: 16546898
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of carcinogen hazard characterisation based on animal studies and epidemiology.
    Sanner T; Dybing E
    Basic Clin Pharmacol Toxicol; 2005 Jan; 96(1):66-70. PubMed ID: 15667598
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nonlinearity and thresholds in dose-response relationships for carcinogenicity due to sampling variation, logarithmic dose scaling, or small differences in individual susceptibility.
    Lutz WK; Gaylor DW; Conolly RB; Lutz RW
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):565-9. PubMed ID: 15982698
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Usefulness of Cyprinodon variegatus and Fundulus grandis in carcinogenicity testing: advantages and special problems.
    Courtney LA; Couch JA
    Natl Cancer Inst Monogr; 1984 May; 65():83-96. PubMed ID: 6431292
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Human cancer risk estimates are reduced when based on relative risk for common rodent tumors.
    Gaylor DW; Kodell RL; Chen JJ
    Regul Toxicol Pharmacol; 1999 Dec; 30(3):283-4. PubMed ID: 10620477
    [No Abstract]   [Full Text] [Related]  

  • 60. Chemically induced cancers in hormonal organs of laboratory animals and of humans.
    Huff J
    Prog Clin Biol Res; 1996; 394():77-102. PubMed ID: 8778812
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.